TR200501948A2 - Farmasötik süspansiyon bileşimi. - Google Patents
Farmasötik süspansiyon bileşimi.Info
- Publication number
- TR200501948A2 TR200501948A2 TR2005/01948A TR200501948A TR200501948A2 TR 200501948 A2 TR200501948 A2 TR 200501948A2 TR 2005/01948 A TR2005/01948 A TR 2005/01948A TR 200501948 A TR200501948 A TR 200501948A TR 200501948 A2 TR200501948 A2 TR 200501948A2
- Authority
- TR
- Turkey
- Prior art keywords
- suspension composition
- pharmaceutical suspension
- soluble
- water
- oral liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Aglomerasyon ve faz ayrımı oluşumuna karşı azaltılmış eğilimi olan ve su içerisinde önemli derecede çözünmez olan bir ya da birden fazla farmasötik aktiflerin süspansiyonu için özellikle geliştirilebilir sulu bir oral sıvı farmasötik bileşim sistemi. Oral sıvı farmasötik bileşim, su içerisinde çözünebilir olan ve sulu ortam içerisinde çözünen farmasötik aktifleri ayrıca içerebilir. Buluşun bileşiminde hem süspansiyonu yapılan hem de çözünen herhangi bir aktif ajan homojen bir şekilde dağıtılmaktadır.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/852,946 US20050266031A1 (en) | 2004-05-25 | 2004-05-25 | Pharmaceutical suspension composition |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200501948A2 true TR200501948A2 (tr) | 2006-01-23 |
Family
ID=35425554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2005/01948A TR200501948A2 (tr) | 2004-05-25 | 2005-05-24 | Farmasötik süspansiyon bileşimi. |
Country Status (9)
Country | Link |
---|---|
US (4) | US20050266031A1 (tr) |
EP (2) | EP2465497A1 (tr) |
CN (1) | CN1988893A (tr) |
CA (1) | CA2567075C (tr) |
MX (1) | MXPA06013481A (tr) |
TR (1) | TR200501948A2 (tr) |
TW (1) | TW200600118A (tr) |
WO (1) | WO2005115353A1 (tr) |
ZA (1) | ZA200504239B (tr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060045891A1 (en) * | 2004-08-24 | 2006-03-02 | Lovalenti Phillip M | Density-matched suspension vehicles and pharmaceutical suspensions |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
LT2486942T (lt) | 2004-11-24 | 2019-01-25 | Meda Pharmaceuticals Inc. | Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai |
US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
DOP2006000274A (es) | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
US8940796B2 (en) * | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
KR101495146B1 (ko) | 2006-03-16 | 2015-02-24 | 트리스 파마 인코포레이티드 | 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제 |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
US10022339B2 (en) * | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
DE602006009484D1 (de) | 2006-05-05 | 2009-11-12 | Givaudan Nederland Services B | Zusammensetzung zur Verbesserung von Geschmack |
US20080014274A1 (en) | 2006-07-14 | 2008-01-17 | Wyeth | Enhanced stability phenylephrine liquid compositions |
WO2009152344A2 (en) * | 2008-06-11 | 2009-12-17 | Comgenrx, Inc. | Combination therapy using phosphodiesterase inhibitors |
RU2589697C2 (ru) * | 2009-12-18 | 2016-07-10 | Экзодос Лайф Сайенсиз Лимитед Партнершип | Способы получения стабильных жидких лекарственных препаратов и их композиции |
US8470375B1 (en) | 2010-01-05 | 2013-06-25 | Neos Therapeutics, Lp | Method of formulating and designing liquid drug suspensions containing ion exchange resin particles |
MX346879B (es) | 2010-10-21 | 2017-04-03 | Rtu Pharmaceuticals Llc | Formulaciones de ketorolaco listas para su uso. |
EP2726066B1 (en) | 2011-06-28 | 2021-03-31 | Neos Therapeutics, LP | Dosage forms of amphetamine for oral administration |
BR102012030828A2 (pt) | 2012-12-03 | 2014-09-16 | Ems Sa | Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso |
CN103251590B (zh) * | 2013-05-13 | 2014-12-17 | 中国科学院武汉病毒研究所 | 一种琥珀酸多西拉敏在制备治疗或预防流感病毒药物中的应用 |
CN103860462A (zh) * | 2014-01-14 | 2014-06-18 | 万特制药(海南)有限公司 | 一种盐酸左西替利嗪糖浆剂及制备方法 |
CN106572650B (zh) * | 2014-06-10 | 2021-08-31 | 生物马特里卡公司 | 在环境温度下稳定凝血细胞 |
CN105287554B (zh) * | 2014-12-10 | 2018-10-30 | 沈阳药科大学 | 复方抗感冒药组合物及其用途 |
CN104644993A (zh) * | 2015-03-18 | 2015-05-27 | 天津中医药大学 | 一种中药干混悬剂及其制备方法 |
EP3302430A4 (en) * | 2015-05-29 | 2019-05-29 | codaDose Incorporated | Liquid Formulations of Celecoxib for Oral Administration |
CN106324162B (zh) * | 2015-06-17 | 2018-04-27 | 深圳海王医药科技研究院有限公司 | 一种基于中心切割技术鉴定复方感冒药中降解产物的高效液相色谱-飞行时间质谱联用方法 |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
EP4242628A3 (en) | 2015-12-08 | 2023-11-08 | Biomatrica, INC. | Reduction of erythrocyte sedimentation rate |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
US20210290532A1 (en) | 2017-11-02 | 2021-09-23 | Max Spielberg | Pharmaceutical syrup formulation or suspension |
CN109010837B (zh) * | 2018-10-25 | 2021-09-28 | 千辉药业(安徽)有限责任公司 | 一种具有高溶解性的塞来昔布组合物 |
KR20200053746A (ko) * | 2018-11-09 | 2020-05-19 | (주)아모레퍼시픽 | 졸-겔 조성물 |
DK4081187T3 (da) * | 2019-12-23 | 2024-01-02 | Nutra Essential Otc S L | Flydende sammensætning med ibuprofen og phenylephrin |
WO2022074630A1 (en) * | 2020-10-09 | 2022-04-14 | Auxilla Pharmaceuticals And Research Llp | Liquid oral suspension of favipiravir |
CN112516083B (zh) * | 2020-12-15 | 2023-02-28 | 太阳升(亳州)生物医药科技有限公司 | 布洛芬混悬液及其制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4145440A (en) * | 1977-08-18 | 1979-03-20 | The Upjohn Company | Liquid suspension of an aluminum salt of ibuprofen |
GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
US4427681A (en) * | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US4788220A (en) | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
US4975465A (en) * | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
JP2949448B2 (ja) * | 1992-11-30 | 1999-09-13 | ケーヴィ ファーマセチカル カンパニー | 味を隠された医薬材料 |
EP0620001A1 (en) * | 1993-04-16 | 1994-10-19 | McNEIL-PPC, INC. | Aqueous pharmaceutical suspension and process for preparation thereof |
EP0721335B1 (en) | 1993-10-01 | 2005-08-31 | Roche Palo Alto LLC | Mycophenolate mofetil high dose oral suspensions |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
IT1286496B1 (it) | 1996-11-20 | 1998-07-15 | Leetrim Ltd Dublin | Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria |
US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
GB9625589D0 (en) * | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
WO1998058640A1 (en) * | 1997-06-23 | 1998-12-30 | Mcneil-Ppc | Ibuprofen and diphenhydramine analgesics |
US6184220B1 (en) * | 1998-03-27 | 2001-02-06 | Boehringer Ingelheim Pharma Kg | Oral suspension of pharmaceutical substance |
US6475539B1 (en) * | 1998-05-07 | 2002-11-05 | Abbott Laboratories | Nutritionally complete low pH enteral formula |
US6319513B1 (en) * | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
US6211246B1 (en) * | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
US6515008B1 (en) * | 2000-05-04 | 2003-02-04 | Smithkline Beecham Corporation | Formulation |
US20020028794A1 (en) * | 2000-07-21 | 2002-03-07 | Brubaker Greg Allen | Megestrol acetate suspension |
JP2004535370A (ja) * | 2001-03-05 | 2004-11-25 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 味をマスクした液体製薬学的組成物 |
JP4365107B2 (ja) * | 2001-05-25 | 2009-11-18 | エスエス製薬株式会社 | 医薬組成物 |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
US7300670B2 (en) * | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
US6890558B2 (en) * | 2002-05-31 | 2005-05-10 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
AU2003236521A1 (en) * | 2002-06-13 | 2003-12-31 | Nobex Corporation | Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus |
ATE541562T1 (de) * | 2002-06-17 | 2012-02-15 | Taro Pharmaceuticals Usa Inc | Ibuprofen-suspension |
US20080139528A1 (en) * | 2003-12-10 | 2008-06-12 | Pujara Chetan P | Cefdinir oral suspension |
-
2004
- 2004-05-25 US US10/852,946 patent/US20050266031A1/en not_active Abandoned
-
2005
- 2005-05-23 EP EP12159631A patent/EP2465497A1/en not_active Ceased
- 2005-05-23 CA CA2567075A patent/CA2567075C/en active Active
- 2005-05-23 MX MXPA06013481A patent/MXPA06013481A/es unknown
- 2005-05-23 WO PCT/US2005/018189 patent/WO2005115353A1/en active Application Filing
- 2005-05-23 EP EP05754274A patent/EP1748765A4/en not_active Ceased
- 2005-05-23 TW TW094116754A patent/TW200600118A/zh unknown
- 2005-05-23 CN CNA2005800245987A patent/CN1988893A/zh active Pending
- 2005-05-24 TR TR2005/01948A patent/TR200501948A2/tr unknown
- 2005-05-24 ZA ZA200504239A patent/ZA200504239B/xx unknown
-
2009
- 2009-03-12 US US12/403,081 patent/US20090176884A1/en not_active Abandoned
-
2014
- 2014-01-28 US US14/165,887 patent/US20140142187A1/en not_active Abandoned
-
2016
- 2016-11-11 US US15/349,101 patent/US10238640B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ZA200504239B (en) | 2007-02-28 |
US20090176884A1 (en) | 2009-07-09 |
CA2567075A1 (en) | 2005-12-08 |
US20050266031A1 (en) | 2005-12-01 |
MXPA06013481A (es) | 2007-01-23 |
EP1748765A1 (en) | 2007-02-07 |
WO2005115353A1 (en) | 2005-12-08 |
US20170065567A1 (en) | 2017-03-09 |
TW200600118A (en) | 2006-01-01 |
US20140142187A1 (en) | 2014-05-22 |
EP1748765A4 (en) | 2009-11-18 |
US10238640B2 (en) | 2019-03-26 |
EP2465497A1 (en) | 2012-06-20 |
CA2567075C (en) | 2013-05-14 |
CN1988893A (zh) | 2007-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200501948A2 (tr) | Farmasötik süspansiyon bileşimi. | |
NO20081576L (no) | Preparater og fremgangsmater for fremstilling av darlig vannloselige legemidler med okt stabilitet | |
TR200801336T1 (tr) | Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler. | |
ATE462489T1 (de) | Feste, redispergierbare emulsion | |
DE602007004212D1 (de) | Hydrogele von polysaccharidmischungen für das gewebe-engineering und als wirkstoffträger | |
IL229975A0 (en) | Pharmaceutical compounds containing arsenoic acid, its sodium salt and its antecedents for the treatment of organ cancer and its metastases | |
AR063466A1 (es) | Composiciones detergentes espesadas por agentes tensioactivos que comprenden microfibras de celulosa y sus metodos de preparacion | |
IL178128A0 (en) | Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same | |
ATE437896T1 (de) | Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung | |
BR0113663A (pt) | Composições de pelìcula de pectina | |
FR2894827B1 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations | |
MA31433B1 (fr) | Inhibiteurs de la p70 s6 kinase | |
JP2009531457A5 (tr) | ||
PA8639301A1 (es) | Derivados de piridio-pirimidina, su preparacion, su enterapeutica | |
HK1146386A1 (en) | Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes | |
AR038947A1 (es) | Suspension oral de sabor agradable y metodo | |
CY1112917T1 (el) | Υγρες στοματικες συνθεσεις | |
EE200100104A (et) | 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm | |
ATE485726T1 (de) | Fliessfähige gelatinezusammensetzung | |
EA200501301A1 (ru) | Ментоловые растворы лекарственных препаратов | |
TR200200831T2 (tr) | Siklesonid içeren sulu farmasötik kompozisyon | |
SE0103765D0 (sv) | New use | |
AR054723A1 (es) | Mejoras con respecto a emulsiones | |
TR201909405T4 (tr) | Suda çözünebi̇li̇r vi̇norelbi̇n tuzunun stabi̇l farmasöti̇k bi̇leşi̇mi̇ | |
FR2901701B1 (fr) | Compostions comprenant au moins un derive de l'acide naphtoique et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations |